46 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
PFE Pfizer, Inc. $43.01 $252.13B N/A
Article Searches
Trump's Pep Talk Raises Vaccine Hopes: 4 Stocks to Watch http://www.zacks.com/stock/news/1060885/trumps-pep-talk-raises-vaccine-hopes-4-stocks-to-watch?cid=CS-ZC-FT-analyst_blog|industry_focus-1060885 Sep 21, 2020 - Biotech firms and drugmakers across the globe are pumping in millions of dollars to develop a vaccine to wipe out the deadly coronavirus.
Pharma Stock Roundup: AZN, LLY & PFE's Coronavirus Updates, MRK's New Cancer Deals http://www.zacks.com/stock/news/1060523/pharma-stock-roundup-azn-lly-pfes-coronavirus-updates-mrks-new-cancer-deals?cid=CS-ZC-FT-analyst_blog|stock_roundup-1060523 Sep 18, 2020 - AstraZeneca (AZN) resumes its coronavirus vaccine study in the United Kingdom. Merck (MRK) inks two oncology deals with Seattle Genetics.
Mylan/Pfizer's Upjohn Unit Merger on Track to Close in Q4 http://www.zacks.com/stock/news/1059616/mylan-pfizers-upjohn-unit-merger-on-track-to-close-in-q4?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-1059616 Sep 17, 2020 - The pending merger of Pfizer's (PFE) Upjohn unit with Mylan (MYL) is on track to close in the fourth quarter of 2020 as almost all necessary regulatory clearances are in place.
BioNTech Gets New Funding for Coronavirus Vaccine Development http://www.zacks.com/stock/news/1059153/biontech-gets-new-funding-for-coronavirus-vaccine-development?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-1059153 Sep 16, 2020 - BioNTech (BNTX) receives grant of up to almost $445 million to support development and potential approval of its coronavirus vaccine candidate.
3 Stocks to Buy Now for Growth & Dividends to Counter Low Bond Yields http://www.zacks.com/stock/news/1058770/3-stocks-to-buy-now-for-growth-dividends-to-counter-low-bond-yields?cid=CS-ZC-FT-stocks_in_the_news|investment_ideas-1058770 Sep 15, 2020 - Investors might want to consider buying stocks that also provide income via dividends given the current interest rate environment...
Stock Market News for Sep 15, 2020 http://www.zacks.com/stock/news/1058441/stock-market-news-for-sep-15-2020?cid=CS-ZC--market_news-1058441 Sep 15, 2020 - U.S. stock markets closed higher on Monday reversing some of the losses of the last week.
What If More Than One Company Wins the Coronavirus Vaccine Race? https://www.fool.com/investing/2020/09/13/what-if-more-than-one-company-wins-the-coronavirus/?source=iedfolrf0000001 Sep 13, 2020 - The ability to globally distribute a vaccine is as important as the vaccine itself. To the best-equipped victors go the spoils.
Pharma Stock Roundup: AZN & PFE's Coronavirus Vaccine Updates & FDA Approvals http://www.zacks.com/stock/news/1057022/pharma-stock-roundup-azn-pfes-coronavirus-vaccine-updates-fda-approvals?cid=CS-ZC-FT-analyst_blog|stock_roundup-1057022 Sep 11, 2020 - AstraZeneca (AZN) halts coronavirus vaccine study. FDA approves Roche (RHHBY) and Glaxo's (GSK) medicines.
CEOs of Nine Coronavirus Vaccine Makers Sign Safety Pledge http://www.zacks.com/stock/news/1055691/ceos-of-nine-coronavirus-vaccine-makers-sign-safety-pledge?cid=CS-ZC-FT-analyst_blog|industry_focus-1055691 Sep 09, 2020 - The COVID-19 vaccine developers pledge to observe high ethical standards and sound scientific principles in conducting clinical studies and manufacturing of vaccines.
Stock Market News for Sep1, 2020 http://www.zacks.com/stock/news/1050805/stock-market-news-for-sep1-2020?cid=CS-ZC--market_news-1050805 Sep 01, 2020 - U.S. stock markets closed mostly lower on Monday as investors booked profit after a week-long rally.

Pages: 12345

Page 1>